Abstract
The series of papers in this thematic issue discuss the differences and similarities of foods versus drugs in disease prevention and treatment. The main focus of each contribution is considered in this review. The use as well as advantages and drawbacks of combination therapy employing drugs and foods are also elaborated on. Examples of combining the use of pharmaceuticals and food bioactives including using statins or ezetimibe in conjunction with plant sterols are provided. In summary, the present paper makes a case for adoption of food bioactives in both prevention and treatment approaches to disease, and recommends that functional foods can serve as efficacious adjuncts to pharmacotherapy during all stages of treatment of numerous diseases.
Keywords: Bioactives, drugs, food, functional foods, health promotion, mechanisms of action, genes, health, nutrigenomics, targets
Current Pediatric Reviews
Title:Foods versus Drugs for Health Promotion: Considerations for Future Directions
Volume: 8 Issue: 3
Author(s): Peter J.H. Jones and Stephanie Jew
Affiliation:
Keywords: Bioactives, drugs, food, functional foods, health promotion, mechanisms of action, genes, health, nutrigenomics, targets
Abstract: The series of papers in this thematic issue discuss the differences and similarities of foods versus drugs in disease prevention and treatment. The main focus of each contribution is considered in this review. The use as well as advantages and drawbacks of combination therapy employing drugs and foods are also elaborated on. Examples of combining the use of pharmaceuticals and food bioactives including using statins or ezetimibe in conjunction with plant sterols are provided. In summary, the present paper makes a case for adoption of food bioactives in both prevention and treatment approaches to disease, and recommends that functional foods can serve as efficacious adjuncts to pharmacotherapy during all stages of treatment of numerous diseases.
Export Options
About this article
Cite this article as:
J.H. Jones Peter and Jew Stephanie, Foods versus Drugs for Health Promotion: Considerations for Future Directions, Current Pediatric Reviews 2012; 8(3) . https://dx.doi.org/10.2174/157339612802139460
DOI https://dx.doi.org/10.2174/157339612802139460 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Aging and Oral Health: Effects in Hard and Soft Tissues
Current Pharmaceutical Design Uric Acid and Hypertension
Current Pharmaceutical Design Metabolic Syndrome, Thyroid Function and Autoimmunity - The PORMETS Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Calpain Inhibition: A Therapeutic Strategy Targeting Multiple Disease States
Current Pharmaceutical Design Harnessing the Potential of Long Non-coding RNAs to Manage Metabolic Diseases
Current Pharmaceutical Design Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies DASH Dietary Pattern: A Treatment for Non-communicable Diseases
Current Hypertension Reviews Editorial (Should Chronic Kidney Disease be Considered as a Coronary Heart Disease Equivalent?)
Current Vascular Pharmacology The Role of Matrix Metalloproteinases in Diabetes Mellitus
Current Topics in Medicinal Chemistry Analytical Techniques in Androgen Anabolic Steroids (AASs) Analysis for Antidoping and Forensic Purposes
Mini-Reviews in Medicinal Chemistry The Role of EC-IC Bypass in Critical Cerebral Hemodynamics of Different Origin
Current Hypertension Reviews Fullerenes: From Carbon to Nanomedicine
Mini-Reviews in Medicinal Chemistry Oxytocin in the Heart Regeneration
Recent Patents on Cardiovascular Drug Discovery "Heart Failure: Meeting the Challenges of Surveillance and Knowledge Translation in Resource-poor Settings"
Current Cardiology Reviews Age-Related Pharmacokinetic and Pharmacodynamic Changes and Related Risk of Adverse Drug Reactions
Current Medicinal Chemistry Aβ Monomers, Oligomers and Fibrils: Structural Features
Current Bioactive Compounds Novel Anti-platelet Agents for the Treatment of Stable Angina Pectoris
Current Pharmaceutical Design The Role of Calcium and the L-Type Calcium Channel in Pathological Remodeling of the Heart
Vascular Disease Prevention (Discontinued) Antiapoptotic Effect of Novel Compound from Herba leonuri-Leonurine (SCM-198): A Mechanism Through Inhibition of Mitochondria Dysfunction in H9c2 Cells
Current Pharmaceutical Biotechnology Homocysteine and Hyperhomocysteinaemia
Current Medicinal Chemistry